New targets for schizophrenia treatment beyond the dopamine hypothesis

AC Yang, SJ Tsai - International journal of molecular sciences, 2017 - mdpi.com
Schizophrenia has been primarily associated with dopamine dysfunction, and treatments
have been developed that target the dopamine pathway in the central nervous system …

Connecting neurobiological features with interregional dysconnectivity in social-cognitive impairments of schizophrenia

FW Adraoui, L Douw, GJM Martens… - International journal of …, 2023 - mdpi.com
Schizophrenia (SZ) is a devastating psychiatric disorder affecting about 1% of the world's
population. Social-cognitive impairments in SZ prevent positive social interactions and lead …

From shortage to surge: a developmental switch in hippocampal–prefrontal coupling in a gene–environment model of neuropsychiatric disorders

H Hartung, N Cichon, V De Feo, S Riemann… - Cerebral …, 2016 - academic.oup.com
Cognitive deficits represent a major burden of neuropsychiatric disorders and result in part
from abnormal communication within hippocampal–prefrontal circuits. While it has been …

New drug developments in psychosis: challenges, opportunities and strategies

MS Keshavan, AN Lawler, HA Nasrallah… - Progress in …, 2017 - Elsevier
All currently approved drugs for schizophrenia work mainly by dopaminergic antagonism.
While they are efficacious for psychotic symptoms, their efficacy is limited for negative …

16p11 duplication disrupts hippocampal-orbitofrontal-amygdala connectivity, revealing a neural circuit endophenotype for schizophrenia

GC Bristow, DM Thomson, RL Openshaw, EJ Mitchell… - Cell reports, 2020 - cell.com
Summary Chromosome 16p11. 2 duplications dramatically increase risk for schizophrenia,
but the mechanisms remain largely unknown. Here, we show that mice with an equivalent …

An acetylcholine alpha7 positive allosteric modulator rescues a schizophrenia-associated brain endophenotype in the 15q13. 3 microdeletion, encompassing …

N Gass, W Weber-Fahr, A Sartorius, R Becker… - European …, 2016 - Elsevier
Abstract The 15q13. 3 microdeletion copy number variation is strongly associated with
schizophrenia and epilepsy. The CHRNA7 gene, encoding nicotinic acetylcholine alpha 7 …

Different serum protein factor levels in first‐episode drug‐naive patients with schizophrenia characterized by positive and negative symptoms

N Dai, H Jie, Y Duan, P Xiong, X Xu… - Psychiatry and …, 2020 - Wiley Online Library
Aim The clinical features of schizophrenia can be mainly divided into two symptom domains:
positive and negative. Patients in each symptom domain respond differently to treatments …

Neuroimaging signature of neuropsychiatric disorders

Y Worbe - Current opinion in neurology, 2015 - journals.lww.com
The connectome, which is largely underpinned by the network science and graph theoretical
approaches, is relevant to the field of neuropsychiatry and could be successfully used for the …

Developmental genes and regulatory proteins, domains of cognitive impairment in schizophrenia spectrum psychosis and implications for antipsychotic drug discovery …

JL Waddington, X Zhen… - Frontiers in Pharmacology, 2020 - frontiersin.org
Alongside positive and negative symptomatology, deficits in working memory, attention,
selective learning processes, and executive function have been widely documented in …

Resting‐state functional MRI as a tool for evaluating brain hemodynamic responsiveness to external stimuli in rats

J Paasonen, RA Salo, JK Huttunen… - Magnetic Resonance in …, 2017 - Wiley Online Library
Purpose Anesthesia is a major confounding factor in functional MRI (fMRI) experiments
attributed to its effects on brain function. Recent evidence suggests that parameters obtained …